Showing results (101-110 of 113) with videos related to
Sort By:
Pageof 12
Clinical Science (London, England : 1979)|May 11, 2005
Effect of urocortin 1 infusion in humans with stable congestive cardiac failureMark E Davis, Christopher J Pemberton, Timothy G Yandle, et al.The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Urocortin-1 infusion in normal humansMark E Davis, Chris J Pemberton, Timothy G Yandle, et al.Nature|March 23, 2010
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesMark E Davis, Jonathan E Zuckerman, Chung Hang J Choi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivoJeremy D Heidel, Joanna Yi-Ching Liu, Yun Yen, et al.Journal of the American College of Cardiology|January 30, 2007
Urocortin 2 infusion in healthy humans: hemodynamic, neurohormonal, and renal responsesMark E Davis, Christopher J Pemberton, Timothy G Yandle, et al.Bioconjugate Chemistry|July 22, 2004
Cyclodextrin-modified polyethylenimine polymers for gene deliverySuzie H Pun, Nathalie C Bellocq, Aijie Liu, et al.Proceedings of the National Academy of Sciences of the United States of America|June 6, 2012
Metalloenzyme-like catalyzed isomerizations of sugars by Lewis acid zeolitesRicardo Bermejo-Deval, Rajeev S Assary, Eranda Nikolla, et al.Journal of Gastrointestinal Oncology|January 5, 2018
Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancerJoseph Chao, James Lin, Paul Frankel, et al.Cancer Biology & Therapy|May 12, 2004
Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particlesSuzie H Pun, Frederik Tack, Nathalie C Bellocq, et al.Nature Medicine|October 6, 2009
Development of universal antidotes to control aptamer activitySabah Oney, Ruby T S Lam, Kristin M Bompiani, et al.Pageof 12